| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000013929 |
| Receipt No. | R000016242 |
| Official scientific title of the study | Clinical evaluation of tau-imaging PET tracer [18F]THK-5351 |
| Date of disclosure of the study information | 2014/05/19 |
| Last modified on | 2018/05/15 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Clinical evaluation of tau-imaging PET tracer [18F]THK-5351 | |
| Title of the study (Brief title) | Clinical evaluation of PET tracer [18F]THK-5351 | |
| Region |
|
|
| Condition | ||||||
| Condition | Alzheimer's disease and healthy volunteer | |||||
| Classification by specialty |
|
|||||
| Classification by malignancy | Others | |||||
| Genomic information | NO | |||||
| Objectives | |
| Narrative objectives1 | This study is aimed at evaluating the clinical usefulness of [18F]THK-5351 as a PET tracer for tau imaging, by the comparison with amyloid PET tracer [11C]PiB in the patients with Alzheimer's disease and healthy volunteers. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Regional [18F]THK-5351 and [11C]PiB retention in the brain, referenced to cerebellar cortex. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | [18F]THK-5351 and [11C]PiB PET studies will be performed in the patients with Alzheimer's disease and healthy volunteers. Both PET scans will be performed within 3 months interval.
Dynamic PET images of the brain will be acquired for 90 min after intravenous administration of 185 mBq [18F]THK-5351, and for 70 min after intravenous administration of 296 MBq [11C]PiB. |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Healthy normal subjects without cognitive impairment and cerebrovascular lesion, and probable Alzheimer's disease patients (NINCDS-ADRDA criteria) | |||
| Key exclusion criteria | Subjects with neuropsychiatric diseases other than Alzheimer's disease, subjects with severe cardiac abnormalities, and subjects with pacemaker or metal device in the body. | |||
| Target sample size | 19 | |||
| Research contact person | |
| Name of lead principal investigator | Nobuyuki Okamura |
| Organization | Tohoku University School of Medicine |
| Division name | Department of Pharmacology |
| Address | 2-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan |
| TEL | 022-717-8058 |
| nookamura@med.tohoku.ac.jp | |
| Public contact | |
| Name of contact person | Nobuyuki Okamura |
| Organization | Tohoku University School of Medicine |
| Division name | Department of Pharmacology |
| Address | 2-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan |
| TEL | 022-717-8058 |
| Homepage URL | |
| nookamura@med.tohoku.ac.jp | |
| Sponsor | |
| Institute | Tohoku University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ministry of Health, Labour and Welfare |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東北大学サイクロトロンRIセンター、東北大学病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000016242 |